Spearhead Capital Advisors, LLC

SEC CIK: 0001718982
Latest filing: Nov 9, 2022

SEC filings (opens in a new tab)

ITCI holding history

Intra-Cellular Therapies, Inc. in every 13F filed by Spearhead Capital Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ITCI overview All 13F holders of ITCI Full Q3 2022 holdings

Shares (Q3 2022): 0; Sold out in Q3 2022
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q1 2022

Holdings of ITCI by Spearhead Capital Advisors, LLC, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2022	0	$0	0.0%	−6,401−100.0%	Sold out	Holders
Q2 2022	6,401	$365.0K	0.1%	−82−1.3%	Reduced	Holders
Q1 2022	6,483	$397.0K	<0.1%	+6,483	New	Holders